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Abstract 
Amyloidosis is a group of diverse disorders that fall into several major categories: 
primary, secondary, dialysis-associated, and hereditary forms. Clinically, amyloidosis 
may be categorized as localized or systemic. The gastrointestinal tract is among the 
most common places for deposition of amyloid, but large, localized amyloid deposits 
are an uncommon occurrence and rarely cause extraluminal bowel compression 
resulting in obstruction as was seen in the case presented in this clinical scenario. 
Introduction 
Amyloidosis is a group of diverse disorders characterized by extracellular deposits 
of abnormally folded protein that interferes with tissue function. These proteins form 
fibrillar, insoluble deposits with specific staining characteristics [1, 2]. Amyloidosis falls 
into several major categories: primary, secondary, dialysis-associated, and a variety of 
hereditary forms [2]. More than 25 different proteins are known to be involved in 
amyloidosis [1]. 
Primary amyloidosis is the most common form and is associated with the deposition 
of excess immunoglobulin light chains. This form is associated with multiple myeloma, 
lymphoma, and other lymphoproliferative disease. Secondary amyloidosis is associated 
with deposition of serum amyloid protein A in inflammatory and infectious conditions. 
Neoplastic conditions are less frequently associated with secondary amyloidosis. Patients 
on long-term hemodialysis form β2 microglobulin deposits [1–4]. 
Amyloid deposits share distinct immunohistochemical characteristics and, at present, 
Congo Red staining of involved tissues remains the gold standard for detection [1]. These Case Rep Gastroenterol 2011;5:315–319 
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deposits appear pink under bright-field microscopy and have apple-green birefringence 
under polarized light. These two characteristics in combination are considered diagnostic 
of amyloid. 
Clinically, amyloidosis may be categorized as localized or systemic [1]. Some forms 
are exclusively localized, including some cerebral amyloidoses, but most exist in both 
localized and systemic forms. In either case, the goals of treatment are to prevent organ 
dysfunction and to eliminate the source of the abnormal protein [1, 2]. 
The gastrointestinal tract is among the most common places for deposition of amyloid. 
The mouth is involved in 10–20% of primary amyloidosis patients, most commonly as 
macroglossia [2]. The esophagus, with symptoms including dysphagia, heartburn, and 
hematemesis, is involved in 13–22% of patients [2]. The stomach is involved in 8–12% of 
patients, but is usually asymptomatic [2, 5]. The small bowel is involved in up to 31%. 
Small bowel manifestations include diarrhea, constipation, obstruction, ischemia, and 
infarction [2, 3]. Large bowel involvement presents with symptoms mimicking ischemia, 
malignancy, or irritable bowel disease and can eventually result in obstruction, stricture, 
and perforation [2, 4]. 
Large, localized deposition of amyloid is an uncommon occurrence and gives rise to 
amyloid pseudo-tumor, or ‘amyloidoma’ [4]. Amyloidomas have been described in a 
variety of organs, including the heart, lungs, larynx, tongue, orbits, mediastinum, breast, 
bones, stomach, small bowel, and colon [1–8]. 
We report a patient who presented with signs of bowel obstruction and was found to 
have a multitude of small amyloid implants throughout the abdomen and a solitary large 
amyloidoma encasing the ureters and rectosigmoid colon, resulting in obstruction. 
Case Report 
The patient was an 82-year-old male with a history of hypertension, osteoarthritis, and coronary 
artery disease who was in his usual state of fair health until approximately 3 years prior to the current 
hospital admission. At that time he noticed a slowly enlarging mass beneath his right mandible. A 
biopsy was performed that showed cells suggestive of a lymphoma. He then underwent resection of his 
submandibular gland for what was ultimately found to be an extranodal marginal zone B-cell MALT 
(mucosa-associated lymphoid tissue) lymphoma. He was treated at that time with cyclophosphamide, 
vincristine, and prednisone, and later with rituximab. Bone marrow biopsy showed no evidence of 
lymphoma. Laboratory studies showed that total serum protein, gamma chains, α1 protein, 1α2 protein, 
IgG, IgM, and β2 microglobulin were all elevated (table 1). 
The patient again presented to medical attention approximately 12 months ago due to symptoms 
of constipation and partial bowel obstruction. Physical examination at that time showed a chronically 
ill-appearing elderly man with a distended abdomen and mild tenderness to deep palpation in the 
region of the umbilicus; there was no rebound tenderness and no guarding. Computed tomography 
of the abdomen showed a pelvic mass that measured 7.0 cm in greatest dimension and was localized to 
the left pelvic wall in the region of the rectosigmoid junction. Over the intervening 12 months he 
underwent additional rounds of chemotherapy and radiation for what was presumed to be a part of his 
lymphoproliferative disease, but was never proven on biopsy. 
At the time of his final hospitalization, again for symptoms of bowel obstruction, he underwent a 
barium enema that showed a significant stricture at the rectosigmoid junction. The pelvic mass had 
progressively grown in size and now caused near-complete colonic obstruction. A contrast enema just 
prior to surgery revealed a string sign consistent with a long-segment, non-transient stricture of the Case Rep Gastroenterol 2011;5:315–319 
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colon at the rectosigmoid junction. Computed tomography confirmed the location of the enlarged mass 
in the pelvis (fig. 1). 
The patient was taken to the operating room for exploratory laparotomy with the intention of 
resecting the pelvic mass to relieve his obstruction. At laparotomy, he was found to have multiple 
small nodules in the abdomen and pelvis not visualized on CT scan. The dominant mass was found 
in the pelvis and completely encased his ureters, the iliac vessels, and the rectosigmoid colon. Given the 
extent of disease, it was felt that the mass could not be safely resected and to relieve his obstruction an 
end-colostomy was created. Microscopic examination of the multiple nodules that were excised showed 
extensive amyloid deposition. This histological finding was confirmed by typical findings on Congo Red 
staining (fig. 2). Special stains to determine the specific protein responsible for forming the amyloidoma 
were not performed. 
The patient survived for approximately 2 months after surgery and died in hospice care. 
Discussion 
Amyloidoma is an uncommon manifestation of amyloidosis. Abnormal glycoprotein, 
usually light chain immunoglobulin, or less commonly serum amyloid A protein, is 
deposited locally, forming a solitary mass. Amyloidomas have been reported in a variety 
of anatomical sites including the gastrointestinal tract, central and peripheral nervous 
systems, soft tissue, bone, and the lung [7]. The distribution of amyloid usually displays 
an organ preference determined by its type [6]. The gastrointestinal tract is involved in 
70–100% of patients. MALT lymphomas of the stomach are frequently associated with 
gastric Helicobacter pylori colonization, which this patient did not have. When MALT 
tumors are found at other sites they are frequently associated with chronic autoimmune 
diseases. MALT lymphomas have been associated with amyloidomas on a number of 
occasions and there are reported cases in whom intraluminal amyloidoma was the cause 
of intestinal obstruction [3, 4]. This is the first report we are aware of in which an 
extraluminal amyloidoma caused bowel obstruction by external compression. 
The lack of specific radiological characteristics makes a preoperative diagnosis of 
amyloidoma extremely difficult. It is often mistaken for a malignant neoplasm such as 
metastatic carcinoma or lymphoma, and while it is not a true neoplastic process, 
amyloidosis can have devastating consequences for the patient. Accurate diagnosis is only 
possible with histological examination of the involved tissues. Staining with Congo Red 
and observation of apple-green birefringence under polarized light is essential to detect 
amyloid deposits [1]. 
Management of this patient’s disease was complicated due to extensive spread 
throughout the peritoneal cavity and its proximity to vital structures. Surgical debulking 
has been described in treatment of limited disease by relieving the space-occupying 
effects of the amyloidoma [7]. Radiotherapy can be used to decrease the size of 
bone-occupying lesions. Aggressive chemotherapy has been used in cases where 
underlying lymphoproliferative disorders were known, sometimes in combination with 
marrow ablation and stem cell rescue [1, 3]. This patient’s underlying extranodal 
marginal zone B-cell MALT lymphoma complicated the picture as amyloidosis is very 
rare in this subtype of malignancy. This erroneous assumption led to treatment of 
peritoneal disease for over a year with chemotherapy and radiation targeted at the 
lymphoproliferative malignancy without knowledge of the amyloidosis component. This 
case highlights the difficulty in diagnosis and management of this uncommon condition Case Rep Gastroenterol 2011;5:315–319 
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in combination with an underlying lymphoma, and the overall poor prognosis of 
disseminated amyloidosis. 
 
 
 
Table 1. Selected laboratory values 
Test Value  Normal  range 
Total serum protein  8.2  5.8–8.0 
Gamma chains  2.1  0.48–1.34 
α1 protein  0.4  0.1–0.3 
α2 protein  1.1  0.48–1.34 
IgG 2,108  666–1,494 
IgM 418  25–231 
β2 microglobulin  3.17  <1.85 
 
 
 
 
 
Fig. 1. Computed tomography of the abdomen demonstrates a pelvic mass with encasement of the left 
ureter and near-complete obstruction of the sigmoid colonic lumen (arrow). 
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Fig. 2. Histopathology demonstrates typical amorphous pink staining under bright-field microscopy 
(black arrows) and apple-green birefringence on Congo Red staining under polarized light (white 
arrows). Magnification 120×. 
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